On 14 June the 20 DHB Chief Executives agreed an Offer for pharmacy owners on funding for Margins and subsidised unregistered medicines (section 26 / section 29). This Offer has been refined from the original proposal that went out for consultation in late March, following significant feedback from you.
Sector agents, DHBs and the Ministry worked together to address your feedback and refine the Offer, however this has meant that Implementation will be 1 August 2016 rather than 1 July 2016. Sector agents support the refined Offer and we thank them for engaging constructively to find a solution all parties could support.
The Voluntary Variation, Offer and Formal Notification
Community pharmacy owners who have signed a Variation or "The Offer" have been sent a formal notice of the variation of the CPSA under clause L6 (a) by their DHBs. This took effect 1 August 2016.
|Formal notice of variation|
|Voluntary Variation to the CPSA|
Consultation on the pharmaceutical margins and subsidised unregistered medicines (section 26 & 29) closed on 22 April 2016.
Significant feedback was received with over 640 individual submissions from 980 pharmacies. A wealth of thoughts and comments were provided throughout the consultation feedback. A snapshot of the comments and a more detail on the themes is provided in the Summary Report.
|Summary report of consultation feedback from Consultation|
In January 2015 the Community Pharmacy Services Governance Group (CPSGG) agreed to establish the Pharmaceutical Margin Taskforce to provide advice on how this issue could be addressed from community pharmacy.
Task force members
The Taskforce members have representation from the Ministry of Health, Pharmacy Sector, PHARMAC and DHBs with support from the Community Pharmacy Services Programme. Andy Inder (Ministry of Health) as Chair.
- Andy Inder - Chair (Ministry of Health)
- Michael Ryan (Project Manager)
- Sean Dougherty (PHARMAC)
- Ken Orr (Pharmacy Sector Representative)
- Mike James (DHB Representative)
- David Mitchell (Pharmacy Sector Representative)
|RFI Section 26/29 Medicines|
|Sapere 'Think Piece'|
|Summary of Discussion Document Feedback|
|Deloitte Environmental Scan|
|Pharmaceutical Margins in CPSA Extension feedback|
|Update for Contract Holders & Guiding Principles for DHBs|